Skip to main content

brivaracetam

Generic: BRIVARACETAM·Brand: BRIVARACETAM, BRIVIACT, Briviact

brivaracetam: 2 clinical trials tracked.

brivaracetam evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about brivaracetam, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Adjunctive Brivaracetam in Subjects (>=16 to 80 Years of Age) With Partial Seizures With or Without Secondary Generalization

NCT03083665Registry updated 2025-10-14·Phase 3
Completed

Primary endpoint: Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)

InterventionalRandomizedquadruple449 enrolledStarted 2017-08Completion 2022-0650 sites · China, JapanUCB Biopharma SRL

An Open-Label, Multicenter, Follow-up Study to Evaluate the Long-Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

NCT03250377Registry updated 2025-07-29·Phase 3
Completed

Primary endpoint: Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)

Interventionalopen207 enrolledStarted 2017-08Completion 2024-1250 sites · China, JapanUCB Biopharma SRL